Project

M14-533

Automatically Closed ยท 2017 until 2022

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2017
End Date
2022
Financing
Industry
Brief description/objective

A Phase 3 Multicenter, Long-Term Extension Study
to Evaluate the Safety and Efficacy of Upadacitinib
(ABT-494) in Subjects with Ulcerative Colitis